David Ira Rosenthal

Radiation Oncology MD Anderson Cancer Center, Houston, TX, United States 
"David Rosenthal"


Sign in to add mentor
Eli Glatstein grad student Penn
Joel Tepper post-doc UNC School of Medicine
 (Resident at UNC)


Sign in to add trainee
Clifton David Fuller research assistant 2002-2006 MD Anderson Cancer Center
Amy C Moreno post-doc 2017-
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Koutroumpakis E, Mohamed ASR, et al. (2023) Longitudinal Changes in the Carotid Arteries of Head and Neck Cancer Patients Following Radiation Therapy: Results from a Prospective Serial Imaging Biomarker Characterization Study. Medrxiv : the Preprint Server For Health Sciences
Rooney MK, Andring LM, Corrigan KL, et al. (2023) Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio. Cancers. 15
Roldan CJ, Rosenthal DI, Koyyalagunta D, et al. (2023) Methylene Blue for the Treatment of Radiation-Induced Oral Mucositis during Head and Neck Cancer Treatment: An Uncontrolled Cohort. Cancers. 15
Sahin O, Wahid KA, Taku N, et al. (2023) Multi-Specialty Expert Physician Identification of Extranodal Extension in Computed Tomography Scans of Oropharyngeal Cancer Patients: Prospective Blinded Human Inter-Observer Performance Evaluation. Medrxiv : the Preprint Server For Health Sciences
Caudell JJ, Torres-Saavedra PA, Rosenthal DI, et al. (2022) Long-term update of NRG/RTOG 0522: a randomized phase III trial of concurrent radiation and cisplatin with or without cetuximab in locoregionally advanced head and neck cancer. International Journal of Radiation Oncology, Biology, Physics
Michikawa C, Torres-Saavedra PA, Silver NL, et al. (2022) Evolutionary Action Score of Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234. Advances in Radiation Oncology. 7: 100989
Gillison ML, Ferris RL, Harris J, et al. (2022) Safety of nivolumab added to chemoradiotherapy platforms for intermediate and high-risk local-regionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504. International Journal of Radiation Oncology, Biology, Physics
Ng SP, Cardenas CE, Bahig H, et al. (2022) Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study. Current Oncology (Toronto, Ont.). 29: 6303-6313
Kiong KL, Moreno A, Vu CN, et al. (2022) Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival. Oral Oncology. 130: 105906
Taku N, Chronowski G, Gunn GB, et al. (2022) Unilateral Radiotherapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papilloma Virus (HPV), Positron-emission Tomography (PET) and Intensity-modulated Radiation Therapy (IMRT). International Journal of Radiation Oncology, Biology, Physics
See more...